Free Trial

OpGen (OPGN) Competitors

OpGen logo
$0.72 +0.01 (+2.04%)
(As of 12/20/2024 03:31 PM ET)

OPGN vs. CCM, MRAI, TOI, PMD, BRTX, KDLY, OTRK, MGRX, ATPC, and VSEE

Should you be buying OpGen stock or one of its competitors? The main competitors of OpGen include Concord Medical Services (CCM), Marpai (MRAI), Oncology Institute (TOI), Psychemedics (PMD), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Ontrak (OTRK), Mangoceuticals (MGRX), Agape ATP (ATPC), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry.

OpGen vs.

Concord Medical Services (NYSE:CCM) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

In the previous week, Concord Medical Services and Concord Medical Services both had 1 articles in the media. Concord Medical Services' average media sentiment score of 0.00 equaled OpGen'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Concord Medical Services
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OpGen
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

OpGen received 104 more outperform votes than Concord Medical Services when rated by MarketBeat users. However, 61.76% of users gave Concord Medical Services an outperform vote while only 53.56% of users gave OpGen an outperform vote.

CompanyUnderperformOutperform
Concord Medical ServicesOutperform Votes
197
61.76%
Underperform Votes
122
38.24%
OpGenOutperform Votes
301
53.56%
Underperform Votes
261
46.44%

2.7% of OpGen shares are held by institutional investors. 46.5% of Concord Medical Services shares are held by company insiders. Comparatively, 43.8% of OpGen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Concord Medical Services has a beta of -0.36, suggesting that its share price is 136% less volatile than the S&P 500. Comparatively, OpGen has a beta of -0.62, suggesting that its share price is 162% less volatile than the S&P 500.

Concord Medical Services has a net margin of 0.00% compared to OpGen's net margin of -1,140.36%.

Company Net Margins Return on Equity Return on Assets
Concord Medical ServicesN/A N/A N/A
OpGen -1,140.36%N/A -287.58%

OpGen has lower revenue, but higher earnings than Concord Medical Services.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Concord Medical Services$471.70M0.04-$41.93MN/AN/A
OpGen$2.67M2.26-$32.67MN/AN/A

Summary

Concord Medical Services beats OpGen on 6 of the 10 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OPGN vs. The Competition

MetricOpGenMedical laboratories IndustryMedical SectorNASDAQ Exchange
Market Cap$6.05M$2.93B$5.12B$9.07B
Dividend YieldN/A15.63%4.91%4.22%
P/E RatioN/A16.0291.3417.19
Price / Sales2.26284.461,117.70116.80
Price / CashN/A472.1142.6437.86
Price / Book-0.065.194.794.78
Net Income-$32.67M-$32.86M$120.07M$225.60M
7 Day Performance-34.73%-3.01%-1.90%-1.23%
1 Month Performance-59.97%2.96%11.45%3.37%
1 Year Performance-82.75%12.37%30.63%16.58%

OpGen Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OPGN
OpGen
N/A$0.72
+2.0%
N/A-82.8%$6.05M$2.67M0.00100Analyst Forecast
News Coverage
Gap Down
CCM
Concord Medical Services
0.3768 of 5 stars
$4.89
-1.2%
N/A-58.8%$21.23M$471.70M0.00970Analyst Forecast
News Coverage
Gap Down
MRAI
Marpai
N/A$1.20
-4.0%
$6.00
+400.0%
-47.7%$16.49M$34.87M-0.42150Gap Down
TOI
Oncology Institute
2.5303 of 5 stars
$0.21
-4.9%
$2.50
+1,079.2%
-88.1%$16.02M$378.93M-0.29660
PMD
Psychemedics
1.3983 of 5 stars
$2.67
-1.8%
N/A-5.3%$15.73M$22.10M0.00140Insider Trade
Gap Down
High Trading Volume
BRTX
BioRestorative Therapies
3.455 of 5 stars
$1.46
+0.7%
$18.00
+1,132.9%
-11.4%$10.10M$150,000.00-0.917
KDLY
Kindly MD
N/A$1.20
-7.7%
N/AN/A$7.17M$2.88M0.00N/AGap Down
OTRK
Ontrak
2.6188 of 5 stars
$1.58
-3.7%
$45.00
+2,748.1%
-76.2%$6.66M$11.24M-0.15250Positive News
MGRX
Mangoceuticals
1.1854 of 5 stars
$2.52
-3.4%
N/A-96.2%$6.27M$755,000.00-0.453News Coverage
Gap Up
ATPC
Agape ATP
N/A$1.24
-13.3%
N/A-88.5%$4.95M$1.35M-1.9640Positive News
Gap Down
VSEE
Vsee Health
N/A$1.36
-8.7%
N/AN/A$4.90M$6.38M0.00N/ANews Coverage
Gap Down

Related Companies and Tools


This page (NASDAQ:OPGN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners